Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis
NCT ID: NCT01420510
Last Updated: 2013-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
60 participants
INTERVENTIONAL
2011-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness
NCT02994342
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
NCT02709005
Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis
NCT02014428
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022
Evaluation of Efficacy and Safety of Gynomax® XL Ovule
NCT03839875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adelmidrol
Efficacy of Adelmidrol vaginal gel in preventing vaginitis in oncologic patients
Adelmidrol vaginal gel
Application of a Adelmidrol vaginal gel
Placebo
Efficacy of Placebo in preventing vaginitis in oncologic patients
Placebo vaginal gel
Application of a placebo vaginal gel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adelmidrol vaginal gel
Application of a Adelmidrol vaginal gel
Placebo vaginal gel
Application of a placebo vaginal gel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current administration of chemotherapy
Exclusion Criteria
* Vaginal cancer
* Vulvar cancer
* Bacterial vaginitis
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi dell'Insubria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabio Ghezzi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gynecologic Oncology Unit
Varese, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Saginil in vaginitis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.